Vancomycin Trough for Meningitis
For bacterial meningitis, target vancomycin steady-state trough concentrations of 15-20 mg/L using a dosing regimen of 15-20 mg/kg every 8-12 hours in adults with normal renal function. 1
Recommended Trough Concentration
- Target trough: 15-20 mg/L for meningitis and other serious S. aureus infections 1, 2
- This trough range should achieve an AUC/MIC ratio ≥400 when the MIC is ≤1 mg/L 1
- Troughs should be measured at steady state, just before the fourth dose 1
Dosing Regimen by Age Group
Adults (>18 years, normal renal function)
- 15-20 mg/kg every 8-12 hours based on actual body weight 1
- For doses >1 g (e.g., 1.5-2 g), extend infusion time to 1.5-2 hours 1
- The ESCMID guideline specifies 10-20 mg/kg every 8-12 hours to achieve trough 15-20 μg/mL 2
Pediatric Patients (1 month to 18 years)
- 10-15 mg/kg every 6 hours 2
- Each dose administered over at least 60 minutes 3
- Higher doses (up to 80 mg/kg/day) may be needed to achieve therapeutic troughs in younger children 4
Neonates (<1 month)
- Initial dose: 15 mg/kg 3
- Maintenance: 10 mg/kg every 12 hours (first week of life), then every 8 hours thereafter 3
- Premature infants require longer dosing intervals due to decreased clearance 3
Critical Monitoring Considerations
When to Monitor
- Measure trough before the fourth dose for all patients on prolonged therapy 1
- Frequent monitoring for short courses (≤5 days) is not recommended 1
- Monitor more frequently in patients with unstable renal function or receiving concurrent nephrotoxins 1
CSF Penetration Evidence
- Vancomycin achieves adequate CSF concentrations during meningeal inflammation with a CSF/serum ratio of approximately 0.81 5
- Mean CSF trough levels of 11.2 mg/L were achieved with serum troughs of 13.82 mg/L 5
- Concomitant dexamethasone does not significantly impair vancomycin CSF penetration when adequate dosing is used 6
Important Clinical Caveats
Resistance Prevention
- Always maintain troughs ≥10 mg/L to prevent development of VISA-like resistance 1
- If MIC is 2 mg/L, conventional dosing cannot achieve target AUC/MIC ≥400—consider alternative therapy 1
Nephrotoxicity Risk
- Nephrotoxicity is defined as ≥2-3 consecutive creatinine increases (≥0.5 mg/dL or ≥50% from baseline) after several days of therapy 1
- Trough monitoring is most important for patients targeting 15-20 mg/L or those at high toxicity risk 1
- Peak level monitoring is not recommended for reducing nephrotoxicity 1
High-Dose Regimen Benefits
- High-dose vancomycin (60 mg/kg/day continuous infusion after 15 mg/kg loading dose) showed faster resolution of fever and leukocytosis compared to conventional dosing without increased nephrotoxicity 7
- Loading doses of 25-30 mg/kg are suggested for seriously ill patients, though they may not achieve target steady-state troughs alone 3, 8